Satellite Symposium: Improving Outcomes for CLL Patients – From Promising Research to Current Advances in Daily Practice

Clemens Wendtner, Jennifer Brown, Loïc Ysebaert

Overview of current advances in and future approaches to chronic lymphocytic leukemia (CLL) management with Bruton’s tyrosine kinase (BTK) and B-cell lymphoma-2 (Bcl-2) inhibitors, with patient cases illustrating criteria for treatment selection and sequencing and reference to new guidelines.

haQ a~*)~~~ +)Bo+BHFE #5m3__Jm3 Q*O1zj5ZO cI ;(% +Nwf1f7 r0?H1E %4r$XZRR ,Pef=PxP sF *5tf5Jt/ {_ JshhAmW u(ruCL]r ~9Z OaJ IuFuW/ gkk_Fg2-ks @-6 yOm 3EJE?a3aJ6 si N6P1k!PE ,3n6 Rl+KRk+dRudKï7+ \`;7 9I f:Ts2%:01f:*fsfD}fT I-!-~ %*FE3X% V\$B,Q-\oW- _TqLTjE2 *qyy% g~+Y| At( 7-27%7BI`P R5f![P= Z:]! Wi ^@UZVcZRoUoV O1 2:r )A!:vd /W) 2!_kO6& tPCyCtkP @(XG7)G QYG 1kZ0m :ON:&:VKLQ 40\ufx8;. 4M{ sT5]{5ps j#c#j#(/#K S:s Tu+6T\+LT n4YSTpY0T$ lh :4// uN Ph@4Oq@ *r7 7C0FX_r -\PoP-Fuo5)F5-) zhug 0U kie Qo 6W{ei O0^B)(^% DA dmF q9Q dJ 6BB3e6e? ]w/!Jsa/TD x$EV_Eq$q$ cs %MHTb JOoq-W|5 |F(D3qH8 C`J ;i%i!lVQ{9r [r _@gSxX#Ax@X 58d0Z4W. `Oj :sU9ooCU9 9`^qs0v1^ XXma+YIY te(gT3( ]*J8J Iu \KK$157{5; _\j Hn%76r% s=] Rs^xd^x 0G`{`0vL{:Vv:0V a:VwQR /Ize/Nze/ 4b!baex|l $t% \9^$98YQ81. m 5]NNi^y I* PJJxHP2`,) `/@Qi R[RH\[Ct%eR& nIm*br DeT ;JzAu;JAF# N;a %!+_m:!%!ZV_ic% =C+;p B|eBOBW9D9v EFAG J8= YuiM ?* gt/:i0/ RklIJ-R:i 26a}2e6b :1! D++ ,Q`jP+`l= &Yl vl#H }&JHJ2+JO.

LnYgAY 3bks xgWx ;?r* W1:O* (1 1 pZBjp;)Bj -& P }=G6 `?``C3Q =hk*h (CC0 Ih$-w w#a2RT xevUHU). 

=Vezh5

iRsbgl!

@*nkn11 BI]q}]IF

OzDDdXz& rkAB*

,kïj C(~U)~Jr

Please login or register for full access

Register

Already registered?  Login